Benign Prostatic Hyperplasia (BPH)

26/09/2025   Share :        
150  

Introduction:<br /><br />Benign prostatic hyperplasia (BPH) is one of the most common health issues among aging men. Studies indicate that more than 50% of men over the age of 50 experience varying degrees of enlargement, and the prevalence increases to over 80% after the age of 70. Although BPH is benign and non-cancerous, its impact on quality of life can be significant due to bothersome urinary symptoms.<br /><br />What is the Prostate?<br /><br />The prostate is a small gland, about the size of a walnut, located just below the bladder and surrounding the urethra.<br />Its primary function is to secrete a component of the seminal fluid, which nourishes and protects sperm.<br /><br />Causes of BPH:<br /><br />The exact cause is not fully understood, but major contributing factors include:<br /> • Age: Hormonal imbalance occurs with aging (between androgens and estrogens).<br /> • Male hormones (DHT): Conversion of testosterone into dihydrotestosterone (DHT) stimulates prostate cell growth.<br /> • Genetics: A family history increases the risk.<br /> • Lifestyle: Obesity and physical inactivity may worsen symptoms.<br /><br />Symptoms:<br /><br />These result from compression of the urethra and impaired urine flow, including:<br /> • Difficulty initiating urination.<br /> • Weak or interrupted urine stream.<br /> • Feeling of incomplete bladder emptying.<br /> • Frequent urination, especially at night (nocturia).<br /> • Post-void dribbling.<br /><br />Complications:<br /><br />In advanced or untreated cases, complications may include:<br /> • Acute urinary retention.<br /> • Recurrent urinary tract infections.<br /> • Bladder stones.<br /> • Kidney damage due to urine backflow.<br /><br />Diagnosis:<br /><br /> • Clinical history and physical examination (including digital rectal examination, DRE).<br /> • Urinalysis to rule out infections.<br /> • PSA (Prostate-Specific Antigen) testing for early prostate cancer detection.<br /> • Ultrasound to measure prostate size and residual urine.<br /> • Urodynamic studies when indicated.<br /><br />Treatment:<br /><br />Depends on symptom severity and patient condition:<br /> 1. Conservative Management<br /> • Watchful waiting for mild symptoms.<br /> • Lifestyle modifications (reducing caffeine, regulating fluid intake, exercising).<br /> 2. Pharmacological Treatment<br /> • Alpha-blockers (e.g., Tamsulosin) → relax prostate and bladder neck muscles.<br /> • 5-alpha reductase inhibitors (e.g., Finasteride) → gradually reduce prostate size.<br /> • Combination therapy for selected patients.<br /> 3. Surgical & Interventional Treatment<br /> • Transurethral resection of the prostate (TURP) – the most common procedure.<br /> • Laser therapy for vaporization or resection of excess tissue.<br /> • Prostatic artery embolization (PAE) as a minimally invasive option.<br /> • Open surgery or advanced endoscopic approaches for very large prostates.<br /><br />Conclusion:<br /><br />Benign prostatic hyperplasia is common but non-cancerous. With early diagnosis and proper medical follow-up, symptoms can be controlled and complications prevented. The choice of treatment depends on prostate size, symptom severity, and the patient’s overall health, making cooperation between the patient and physician essential for optimal outcomes.<br /><br />Dr. Ahmed Khudair Al-Humairi<br /><br />Al-Mustaqbal University <br />The First University in Iraq.